[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100475288":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":18,"responsibleParty":38,"collaborators":7,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":7,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Henan Cancer Hospital","OTHER_GOV",null,[9],{"type":10,"name":11,"description":11,"armGroupLabels":7,"otherNames":7},"OTHER","NO Intervention",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Wang Jiaqiang, Dr.","CONTACT","13592413731","wjqwtj@126.com",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Department of Bone and Soft Tissue ,Henan Cancer Hospital","RECRUITING","Zhengzhou","Henan","450008","China","CN",{"type":28,"coordinates":29},"Point",[30,31],113.64861,34.75778,{"lat":31,"lon":30},[34],{"name":35,"role":15,"phone":36,"phoneExt":7,"email":37},"Zhichao Tian, Dr.","+8618737187831","tianzhichhaoyy@163.com",{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Wang Jiaqiang","Associate chief physician","100475288","study-on-clinical-features-treatment-mode-and-survival-of-bone-and-soft-tissue-tumors-100475288",false,"NCT05468970","Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors","Single-center Real World Prospective Observational Study of Clinical Features, Treatment Patterns, and Survival of Bone and Soft Tissue Tumors","Inclusion Criteria:\n\nAll ages, male and female.\n\nThe pathological diagnosis of BSTS in our hospital was a subtype.\n\nHas received at least one hospitalization in this hospital.\n\nThe target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes.\n\nExclusion Criteria:\n\nNo definite pathology.","ALL","6 Years","99 Years",{"count":53,"type":54},6000,"ESTIMATED","OBSERVATIONAL","It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.",[58,59],"Bone and Soft Tissue Tumors","Clinical Features","2023-08-31",{"date":62,"type":63},"2023-09-01","ACTUAL",{"date":65,"type":63},"2022-08-03",{"date":67,"type":54},"2032-07-31",{"name":5,"class":6},1]